Navigation Links
If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
Date:2/11/2009

Genentech/Roche/Chugai's Drug in Combination With Herceptin and Taxotere Will Become Decision Resources Gold Standard Regimen by 2017, According to a New Report from Decision Resources

WALTHAM, Mass., Feb. 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that if Genentech/Roche/Chugai's Herceptin is approved in combination with emerging therapies, it will be in a position to retain patient share from GlaxoSmithKline's Tykerb/Tyverb for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. This is particularly true in the second- and subsequent HER2-positive treatment lines which are currently its most vulnerable market segments.

The new report entitled HER2-Positive Breast Cancer: Oncologists Are Eager for Improvements in Overall Survival Compared with Trastuzumab in the Metastatic Setting also finds that Genentech/Roche/Chugai's pertuzumab in combination with Herceptin and Sanofi Aventis' Taxotere will become Decision Resources' proprietary clinical gold standard regimen for HER2-positive breast cancer by 2017. This will occur following its approval for the indication in combination with Herceptin and Taxotere in 2013.

"Based on surveys and interviews we conducted with U.S. and European oncologists, as well as comparative drug analysis using our proprietary drug comparator model, we concluded that pertuzumab will have competitive advantages in efficacy when used in combination with Herceptin and Taxotere versus using Herceptin and Taxotere alone," stated Niamh Murphy, Ph.D., analyst at Decision Resources.

About the Report

HER2-Positive Breast Cancer: Oncologists are Eager for Improvements in Overall Survival Compared with Trastuzumab in the Metastatic Setting is a DecisionBase 2009 report. DecisionBase 2009 is a decision-support
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
2. Herceptin helps women with multiple chromosomes containing HER2 gene, study finds
3. Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan
4. Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
5. A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009
6. CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
7. Alliance for Pediatric Quality Supports New ANSI-Approved Standard for Child Health Passed by HL7
8. New Roche Dual Target HIV-1 Test Approved for Use in European Union
9. The First Treatment Specifically Approved for Huntingtons Disease Patients is Now Available in the United States
10. Bayer Marketing Two Unapproved Aspirin Products: FDA
11. Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 AmerisourceBergen’s Innomar Strategies, a ... is now providing U.S. manufacturers access to the ... center coupled with its fully-licensed wholesale and import ... historically been difficult for smaller and mid-tier healthcare ... As a result of these regulations and the ...
(Date:9/23/2014)... The print component of Mental Health is distributed within ... approximately 327,720 copies and an estimated readership of 688,212. ... social media strategy and across a network of top ... version of the campaign, visit http://mentalhealthnews.ca/ . , ... host of TSN’s Off the Record. Landsberg, who battles ...
(Date:9/23/2014)... 2014 Antibiotics revolutionized health care in the ... killed thousands of people. But bacteria are also ... bacteria are popping up more frequently. This week,s ... of new antibiotics and discusses the prospects for ... Why should you finish your pills if you ...
(Date:9/23/2014)... assumed about single parents, particularly single parents of young ... found that single parents of children younger than 5 ... without children -- and more so than single parents ... Behavior Among Single Parents of Young Children in the ... of Sex Research prior to appearing in print. ...
(Date:9/23/2014)... On September 23, 2014, My Positive Perspective founder Jason Deierlein ... the founder of Traveler of Charleston magazine and answered some ... At the start of the interview, Deierlein asked Simmons, “How ... replied by saying, “I had worked for the yellow pages ... and decided to start my own magazine thinking I could ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Paves Path to Canadian Markets 2Health News:AmerisourceBergen Paves Path to Canadian Markets 3Health News:‘Sick, not weak’: Mediaplanet’s "Mental Health” Campaign Dispels Stigmas and Bolsters Support for the One in Five Canadians Suffering Mental Illness 2Health News:Kinsey study of single parents' dating, sexual activity contradicts assumptions 2Health News:My Positive Perspective Airs Episode With the Founder of Traveler of Charleston Magazine 2
... vaccine were ordered on the advice of the Chief Veterinary Officer ... ,The decision was taken after the organic free-range poultry producers requested ... the presence of bird flu and so assist its spread of ... vaccinating the poultry in advance of an avian influenza outbreak should ...
... Glasgow University have used technology developed for digital cameras ... of blindness//, age related macular degeneration and retinitis pigmentosa. ... Glasgow University's physics department, the objective of implanting such ... retina that could "fool" the brain into thinking that ...
... test have found that any kind of exercise will help ... Todd M. Manini, an exercise physiologist at the U.S. National ... saying that self-reported exercise like running or jogging is beneficial. ... a protective value." ,His research team conducted a ...
... of Parliament is to pass a law that would protect ... hospital, along with the right// for a woman with the ... before marriage. ,India is supposedly the country with ... in the world and this bill is being proposed to ...
... microbiology and molecular genetics, and his colleagues from Michigan State ... and potential for growing flu virus. , This is ... new human flu vaccines which is cheaper and produced in ... the new cell line while working on the Marek's disease ...
... A study by Temple University researchers has found that ... though they smoke less cigarettes than Caucasians. The study ... which confirms findings from a smaller preliminary study published ... the distribution of emphysema and the severity of lung ...
Cached Medicine News:Health News:Physical Activity of any kind to Prolong Life 2Health News:New Law On HIV/AIDS To Be Implemented At The Monsoon Session Of Parliament 2Health News:New Cell Lines Cuts Down the Cost and Time in the Production of Flu Vaccine 2Health News:African Americans Have Increased Risk Of Emphysema 2
(Date:9/23/2014)... , September 23, 2014 ... announces the appointment of Jarrod Longcor ... Longcor is responsible for structuring, negotiating and executing ... as well as providing management and strategic leadership ... the Executive leadership team. Mr Longcor ...
(Date:9/22/2014)... , September 23, 2014 , ... health authorities, increasing rigor for trial master file (TMF) ... industry,s largest TMF survey to date reveals an increase ... to provide auditors with remote access to their electronic ... owners surveyed in the Veeva 2014 Paperless ...
(Date:9/22/2014)... 22, 2014 Avanir Pharmaceuticals, Inc. (NASDAQ: ... to sell $200 million of its common stock in ... and BofA Merrill Lynch are acting as joint book-running ... a 30-day option to purchase additional shares of its ... in the offering are being sold by Avanir.  The ...
Breaking Medicine Technology:Avillion Appoints Jarrod Longcor as Chief Business Officer 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
... , ... a new market research report is available in ... - A US Market Review , ... medical adhesives and sealants is gaining preeminence in ...
... Cyberonics, Inc. (Nasdaq: CYBX ) today announced that Dan ... Officer, will present at the 21st Annual Piper Jaffray Health Care ... PM EST. The conference session and webcast will be audio ... will host a webcast of the presentation live and by replay ...
Cached Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2
... GE Healthcare is ... in best-in-class analysis programs ... area monitoring device. With ... 12SL, Gender-Specific, and ACI-TIPI, ...
... The Affinity pacemaker family ... smallest, truly automatic devices. ... combination of advanced technologies ... DR pacemaker incorporates the ...
... small bench top chemistry analyzer that utilizes dry ... with results available within 8 - 15 minutes. ... instrument accepts whole blood samples and is calibrated ... At the conclusion of testing, results are available ...
... is a battery-backed up, microprocessor based, quality instrument ... It stores and displays a chart on its ... scrolled through or zoomed into and out of, ... to 3 months can be seen at one ...
Medicine Products: